CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population

International Journal of Immunogenetics

Volumn 35, Issue 1, 2008, Pages 19-23

  Muro, M ^a   Marin L ^a   Torio, A ^a   Pagan, J A ^a   Alvarez Lopez M R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

POLLEN ANTIGEN; RANTES;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; ASTHMA; ATOPY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; SPAIN; STATISTICAL ANALYSIS;

ADULT; ASTHMA; CHEMOKINE CCL5; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SPAIN;

EID: 37849049256     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00724.x     Document Type: Article

References (42)

1. Al Sharif, F., Ollier, W. E. R. Hajeer, A. H. (1999) A rare polymorphism at position in the human RANTES promoter. European Journal of Immunogenetics, 26, 373.
2. Al-Abdulhadi, S. A., Helms, P. J., Main, M., Smith, O. Christie, G. (2005) Preferential transmission and association of the G→A promoter RANTES polymorphism with atopic asthma. Genes and Immunity, 6, 24.
3. American Thoracic Society 1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. American Review of Respiratory Diseases, 136, 225.
4. An, P., Nelson, G. W., Wang, L., Donfield, S., Goedert, J. J., Phair, J. et al. (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proceedings of the National Academy Sciences, USA, 99, 10002.
5. Azzawi, M., Pravica, V., Hasleton, P. S. Hutchinson, I. V. (2001) A single nucleotide polymorphism at position -109 of the RANTES proximal promoter. European Journal of Immunogenetics, 28, 95.
6. Bisset, L. R. Schmid-Grendelmeier, P. (2005) Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Current Opinion in Pulmonary Medicine, 11, 35.
7. Dupont, W. D. Plummer, W. D. (1990) Power and sample size calculations: a review and computer program. Controlled Clinical Trials, 11, 116.
8. Fryer, A. A., Spiteri, M. A., Bianco, A., Hepple, M., Jones, P. W., Strange, R. C. et al. (2000) The G→A promoter polymorphism in the RANTES gene is associated atopy and asthma. Genes and Immunity, 1, 509.
9. Gonzalez, E., Dhanda, R. Bamshad, M. (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic. Proceedings of the National Academy Sciences, USA, 98, 5199.
10. Hajeer, A. H., Al Sharif, F. Ollier, W. E. R. (1999) A polymorphism at position in the human RANTES promoter. European Journal of Immunogenetics, 26, 375.
11. Hellier, S., Frodsham, A., Henning, B., Klenerman, P., Knapp, S., Ramaley, P. et al. (2003) Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology, 38, 1468.
12. Hizawa, N., Yamaguchi, E., Konno, S., Tanino, Y., Jinushi, E. Nishimura, J. (2002) A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. American Journal of Respiratory and Critical Care Medicine, 166, 686.
13. Kameyoshi, Y., Dorschner, A., Mallet, A. I., Christophers, E. Schroder, J. M. (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. Journal of Experimental Medicine, 176, 587.
14. Kozma, G. T., Falus, A. Bojszko, A. et al 2002) Lack of association between atopic eczema/dermatitis syndrome and polymorphism in the promoter region of RANTES and regulatory region of MCP-1. Allergy, 57, 160.
15. Leung, T. F., Tang, N. L. Lam, C. W. et al 2005) RANTES G-401A polymorphism is associated with allergen sensitization and FEV1 in Chinese children. Respiratory Medicine, 99, 216.
16. Liu, H., Chao, D., Nakayama, E. E., Faguchi, H., Goto, M., Xin, X. et al. (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proceedings of the National Academy Sciences, USA, 96, 4581.
17. Makki, R. F., Al Sharif, F., Gonzalez-Gay, M. A., Garcia-Porrua, C., Ollier, W. E. R. Hajeer, A. H. (2000) RANTES gene polymorphism in polymyalgia rheumatic, giant cells arteritis and rheumatoid arthritis. Clinical and Experimental Rheumatology, 18, 391.
18. Marshall, H. (2001) RANTES polymorphism affects susceptibility to HIV and asthma. Trends in Immunology, 22, 13.
19. McDermott, D. H., Beecroff, M., Kleeberger, C. A., Al-Sharif, F. M., Ollier, W. E., Zimmerman, P. A. et al. (2000) Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS, 14, 2671.
20. Moissidis, I., Chinoy, B. Yanamandra, K. et al 2005) Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans. Genetics in Medicine, 7, 406.
21. Muro, M., Álvarez-López, M. R. Torío, A. et al 1997) HLA-DRB1 and -DQB1 polymorphism in liver recipients: relationship between HLA-DQB1*0302 allele frequency and acute rejection. Human Immunology, 56, 70.
22. Muro, M., Herrero, N. Marín, L. et al 2001a) Polymorphism in the upstream regulatory region of the HLA-DQB1 gene in liver graft recipients. Human Biology, 73, 845.
23. Muro, M., Marín, L. Torío, A. et al 2001b) HLA polymorphism in the Murcia population (Spain) in the cradle of the Archaeological Iberians. Human Immunology, 62, 910.
24. Nakajima, K., Tanaka, Y., Nomiyama, T., Ogihara, T., Ikeda, F., Kanno, R. et al. (2003) RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care, 26, 892.
25. Nelson, P. J., Kim, H. T., Manning, W. C., Goralski, T. J. Krensky, A. M. (1993) Genomic organization and transcriptional regulation of the RANTES chemokine gene. Journal of Immunology, 151, 2601.
26. Nickel, R. G., Casolaro, V., Wahn, U., Beyer, K., Barnes, K. C., Plunkett, B. S. et al. (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. Journal of Immunology, 164, 1612.
27. Ontañón, J., Muro, M. García-Alonso, A. M. et al 1998) Effect of partial HLA-class I match on acute rejection in viral preinfected human liver allograft recipients. Transplantation, 65, 1047.
28. Pattermore, P. K., Johnston, S. L. Bardin, P. G. (1992) Viruses as precipitants of asthma symptoms. I. Epidemiology. Clinical and Experimental Allergy, 22, 235.
29. Petrek, M., Pantelidis, P. South, A. M. et al 1997) The source and role of RANTES in interstitial lung disease. European Respiratory Journal, 10, 1207.
30. Promrat, K., McDermott, D. H., Gonzalez, C. M., Kleiner, D. E., Koziol, D. E., Lessie, M. et al. (2003) Associations of chemokine systems polymorphism with clinic outcomes and treatment responses of chronic hepatitis C. Gastroenterology, 124, 352.
31. Ruffilli, A. Bonini, S. (1997) Susceptibility genes for allergy and asthma. Allergy, 52, 256.
32. Schroppel, B., Fischereder, M. Lin, M. et al 2002) Analysis of gene polymorphism in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients. Journal of Clinical Immunology, 22, 381.
33. Shall, T. J., Bacon, K., Toy, K. J. Goeddel, D. V. (1990) Selective attraction of monocytes and lymphocytes T of the memory phenotype by cytokine RANTES. Nature, 347, 669.
34. Szalai, C., Duba, J. Proháska, Z. et al 2001) Involvement of polymorphism in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence elevated Lp (a) MCP-1 G/C genotype CAD patients. Atherosclerosis, 158, 233.
35. Takada, T., Suzuki, E. Ishida, T. et al 2001) Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. Tissue Antigens, 58, 293.
36. Tanaka, K., Roberts, M. H. Yamamoto, M. et al 2006) Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis. International Journal of Immunogenetics, 33, 423.
37. Torio, A., Sánchez-Guerrero, I. Muro, M. et al 2000) Analysis of the phenotypic distribution of HLA class I and class II in atopic and non-atopic asthma patients. European Journal of Immunogenetics, 27, 81.
38. Torio, A., Sánchez-Guerrero, I. Muro, M. et al 2003) HLA class II genotypic frequencies in atopic asthma. Association of DRB1*01- DQB1*0501 genotype with Artemisia vulgaris allergic asthma. Human Immunology, 64, 811.
39. Vidal, F., Peraire, J. Domingo, P. et al 2006) Polymorphism of RANTES chemokine gene promoter is not associated with long-term nonprogressive HIV-1 infection of more than 16 years. Journal of Acquired Immune Deficiency Syndromes, 41, 17.
40. Wang, D., Bresnahan, W. Shenk, T. (2004) Human cytom egalovirus encodes a highly specific RANTES receptor. Proceedings of the National Academy of Sciences, USA, 101, 16642.
41. Wang, S. Z. Forsyth, K. D. (1998) Asthma and respiratory syncytial virus infection in infancy: is there a link? Clinical and Experimental Allergy, 28, 927.
42. Yao, T. C., Kuo, M. L. See, L. C. et al 2003) The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. Journal of Allergy and Clinical Immunology, 111, 1285.